NYC SESSIONS RELAUNCH
LAST CHANCE | Join us at NYC Sessions tonight
Join us in the heart of the Big Apple tonight for an intimate night of talks, networking, an open bar (providing beer & wine all night), plus dedicated cannabis consumption lounge at the ground breaking women owned Work N Roll in Chelsea.
New York has worked to create and deliver a genuinely transformational legal cannabis framework in the state. Now the first official dispensaries are open and given what we know today, how might the New York market look 10 years from now?
Our panel of four speakers from Leafly, Lucid Green, Uber and the New York State Office of Cannabis Management will discuss and debate what the future holds for the legal cannabis market in New York. Will it live up to the hype?
Where the cannabis sector goes from here
Forbes reports that last year was the first true down cycle the cannabis industry has seen, and today, most indices are at an all-time low.
The publication suggests that there are similarities between the cannabis industry and the tech sector over the first ten years, most prominently, unfettered equity investment on the bet of future performance needed to cease – asking if this pendulum swing from equity to debt will balance itself out in 2023.
Forbes suggests that the legal US cannabis industry will continue to grow, but far more slowly, with a greater focus on profitability.
Medical cannabis patients will have lower expenses thanks to new partnership between Bennabis Health and Canna Care Docs
Bennabis Health and Canna Care Docs have joined forces to provide affordable, reliable resources and safe access for medical cannabis patients, reports Benzinga.
Under the new agreement, patients get a significant reduction in the cost of a Canna Care Docs certification appointment, and will be eligible for a discounted membership with Bennabis Health, further lowering their expenses.
John Agos, CEO of Bennabis Health stated: “Many medical cannabis patients lack the necessary expertise and are left to navigate the process alone. Our partnership offers trustworthy resources to assist patients at any stage of their medical cannabis journey, reducing cost and making it more accessible.”
BREAKING: Love Hemp bought out of administration
BusinessCann reports that Love Hemp has been bought out of administration by Portillion SPV1 Limited for an undisclosed sum.
After officially calling in administrators earlier this month, Love Hemp has now seen its shares withdrawn from the Aquis Stock Exchange, following months of suspension.
In a brief announcement on February 13, the collapsed CBD brand told investors: “Pursuant to Rule 5.2 of the AQSE Growth Market Rules Access, the company will be withdrawn from the AQSE Growth Market with effect from market close 13 February 2023.”
A spokesperson for Love Hemp’s administrators Begbies Traynor told BusinessCann: “The Joint Administrators of Love Hemp Limited, Paul Cooper and Jamie Taylor of Begbies Traynor Group Plc, are delighted to announce that following the marketing and sales process run by their agents Williams & Partners, they have successfully sold the business to Portillion SPV1 Limited.
“ As well as securing the future of the business, Portillion SPV1 Limited will be taking on all the existing employees.”